About the journal
Journal of Pharmaceutical Health Care and Sciences is an open-access journal published by BMC in United Kingdom, publishing in english. It is listed in DOAJ and PUBMED according to the sources read. Declared publication charge: 2,090 EUR. Declared review time at DOAJ: 8 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- BMC
- ISSN
- 2055-0294
- Country
- United Kingdom
- Languages
- english
- Access
- Open access
- Declared publication charge
- 2,090 EUR
- Articles in DOAJ
- 518
- Declared review time
- 8 weeks
- Declared peer-review model
- peer_review
- Official website
- https://jphcs.biomedcentral.com/
Index listings
- DOAJ · 2015-07-08
- PUBMED · 2020-11-02
- Indexing
- DOAJ · PUBMED
- APC
- 2,090 EUR
- Declared review time (DOAJ)
- 8 weeks — journal-declared only (not measured)
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Articles in DOAJ
518
Most recent article
last month
Average review time (journal-declared via DOAJ)
8weeks
Works in OpenAlex
600
Last recorded publication year
2026
h-index
28
i10-index
120
From OpenAlex open data (CC0).
Editorial & policy12
- Last DOAJ review date
- 2026-03-17
- Added to DOAJ
- 2015-07-08
- Declared plagiarism screening
- Declared
- Other fees beyond APC
- No
- Declared digital preservation
- CLOCKSSLOCKSSPMCPortico
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Editorial board
- Official page ↗
- Open references deposited at Crossref
- 90%
- ORCID iDs in current deposits
- 39%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
- APC waiver policy
- View policy
- Peer-review policy
- View policy
Identity & continuity4
- Alternate titles
- JPHCS
- Source type
- journal
- NLM unique ID (PubMed)
- 101672177
- Society affiliations
- Japanese Society of Pharmaceutical Health Care and Sciences
Classification4
Subjects (DOAJ)
LCC codes
Subject areas
- Pharmaceutical Practices and Patient Outcomes
- Pharmaceutical Practices and Patient Outcomes
- Pharmacy and Medical Practices
- Pharmacy and Medical Practices
- Medication Adherence and Compliance
- Pharmacovigilance and Adverse Drug Reactions
- Pharmacovigilance and Adverse Drug Reactions
- Medication Adherence and Compliance
Show all subjects (50)
- Antibiotics Pharmacokinetics and Efficacy
- Antibiotics Pharmacokinetics and Efficacy
- Antibiotic Use and Resistance
- Antibiotic Use and Resistance
- Nausea and vomiting management
- Safe Handling of Antineoplastic Drugs
- Safe Handling of Antineoplastic Drugs
- Nausea and vomiting management
- Pain Management and Opioid Use
- Pain Management and Opioid Use
- Chemotherapy-related skin toxicity
- Atrial Fibrillation Management and Outcomes
- Antimicrobial Resistance in Staphylococcus
- Atrial Fibrillation Management and Outcomes
- Chemotherapy-related skin toxicity
- Antimicrobial Resistance in Staphylococcus
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Pharmaceutical studies and practices
- Pharmaceutical studies and practices
- Cancer Treatment and Pharmacology
- Neutropenia and Cancer Infections
- Neutropenia and Cancer Infections
- Chemotherapy-induced organ toxicity mitigation
- Chemotherapy-induced organ toxicity mitigation
- Renal Transplantation Outcomes and Treatments
- Diabetes Treatment and Management
- Renal Transplantation Outcomes and Treatments
- Heart Failure Treatment and Management
- Drug-Induced Adverse Reactions
- Pharmacogenetics and Drug Metabolism
- Diabetes Treatment and Management
- Drug-Induced Adverse Reactions
- Pharmacogenetics and Drug Metabolism
- Heart Failure Treatment and Management
- HIV/AIDS drug development and treatment
- Potassium and Related Disorders
- HIV/AIDS drug development and treatment
- Antifungal resistance and susceptibility
- Antifungal resistance and susceptibility
- Acute Kidney Injury Research
Keywords (DOAJ)
- clinical pharmacy
- health sciences
- pharmacotherapy
- pharmaceutical health care
- drug informatics
- pharmacoeconomics
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ